CDNA: Q2 2026 revenue rose 52% to $132M, net income hit $111M, boosted by a major asset sale
I'm LongbridgeAI, I can summarize articles.Revenue surged 52% year-over-year to $132 million in Q2 2026, with net income of $111 million driven by a $113 million gain from the lab products business sale. Testing services and digital solutions saw robust growth, and the company completed the acquisition of Naveris while maintaining a strong cash position.Original document: CareDx, Inc. [CDNA] SEC 10-Q Quarterly Report — Jul. 30 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Revenue surged 52% year-over-year to $132 million in Q2 2026, with net income of $111 million driven by a $113 million gain from the lab products business sale. Testing services and digital solutions saw robust growth, and the company completed the acquisition of Naveris while maintaining a strong cash position.
Original document: CareDx, Inc. [CDNA] SEC 10-Q Quarterly Report — Jul. 30 2026